Department of Chemical and Biological Engineering, Princeton University, A301 Engineering Quad, Olden St., Princeton, New Jersey, 08544, USA.
Optimeos Life Sciences, Princeton, New Jersey, USA.
AAPS J. 2020 Jan 2;22(2):18. doi: 10.1208/s12248-019-0405-z.
The encapsulation of water-soluble therapeutics and biologics into nanocarriers to produce novel therapeutics has been envisioned for decades, but clinical translation has been hampered by complex synthesis strategies. The methods that have been developed are often limited by poor encapsulation efficiency/loading or complex processing to achieve therapeutic loadings high enough to be medically relevant. To address this unmet need, we introduce a solubility-driven self-assembly process to form polymeric nanocarriers comprising a biologic in a hydrophilic core, encapsulated by a poly(lactic acid) shell, and stabilized by a poly(ethylene glycol) brush. Called "inverse Flash NanoPrecipitation (iFNP)," the technique achieves biologic loadings (wt% of total formulation) that are 5-15× higher than typical values (9-27% versus < 2%). In contrast to liposomes and polymersomes, we sequentially assemble the polymer layers to form the final nanocarrier. Installation of the poly(lactic acid) shell before water exposure sequesters the biologic in the core and results in the improved loadings that are achieved. We demonstrate the broad applicability of the process and illustrate its implementation by formulating over a dozen different oligosaccharides, antibiotics, peptides, proteins, and RNA into nanocarriers with narrow size distributions, at high loadings, and with high reproducibility. Lysozyme and horseradish peroxidase are shown to retain 99% activity after processing. These results demonstrate the potential for commercial implementation of this technology, enabling the translation of novel treatments in immunology, oncology, or enzyme therapies.
将水溶性治疗药物和生物制剂封装到纳米载体中以产生新的治疗药物的想法已经存在了几十年,但由于复杂的合成策略,临床转化一直受到阻碍。已经开发的方法通常受到封装效率/负载低或复杂加工的限制,无法达到足够高的治疗负载以具有医学相关性。为了解决这一未满足的需求,我们引入了一种基于溶解度的自组装过程,以形成包含生物制剂的亲水性核的聚合物纳米载体,该核被聚乳酸(PLA)壳包裹,并由聚乙二醇(PEG)刷稳定。这种方法称为“反向 Flash 纳米沉淀(iFNP)”,可实现生物制剂负载(占总配方的重量%)比典型值高 5-15 倍(9-27%比<2%)。与脂质体和聚合物囊泡不同,我们依次组装聚合物层以形成最终的纳米载体。在暴露于水之前安装聚乳酸(PLA)壳可将生物制剂隔离在核内,从而实现所达到的改善的负载量。我们展示了该过程的广泛适用性,并通过将十几种不同的寡糖、抗生素、肽、蛋白质和 RNA 制剂成纳米载体,证明了其在高负载量和高重现性下具有窄粒径分布的实现。溶菌酶和辣根过氧化物酶在加工后保留了 99%的活性。这些结果表明该技术具有商业实施的潜力,能够将免疫学、肿瘤学或酶疗法的新型治疗方法转化为临床应用。